TABLE 3.
Prevalence of underweight, stunting, overweight, and % body fat ≥20% among children in the International Lipid-Based Nutrient Supplements (iLiNS)-DYAD Ghana trial at 4–6 y1
| Non-LNS (n = 622) | LNS (n = 338) | OR (95% CI) | P-value | |
|---|---|---|---|---|
| Stunting (HAZ < -2 SD) | — | — | — | |
| Prevalence, % | 6.3 | 6.5 | 1.00 (0.58, 1.73) | 0.993 |
| Underweight (WAZ < -2SD) | — | — | — | |
| Prevalence, % | 5.6 | 6.2 | 1.10 (0.63, 1.93) | 0.730 |
| Overweight (BMIZ > 1 SD) | — | — | — | |
| Prevalence, % | 2.9 | 3.0 | 1.10 (0.47, 2.54) | 0.827 |
| Body fat ≥20% | — | — | — | |
| Prevalence 2, % | 14.3 | 17.4 | 1.26 (0.87, 1.18) | 0.218 |
1Values are the percentage of participants whose response was “yes” for the outcome in question and OR (95% CI) obtained by comparing the groups. Reference = non-LNS group for all outcomes. Results are based on logistic regression (SAS PROC GLIMMIX). BMIZ, BMI-for-age z score; HAZ, height-for-age z score; LNS, lipid-based nutrient supplements group; non-LNS, iron folic acid group + multiple micronutrients group; WAZ, weight-for-age z score.
2Values are based on less than the full sample for overweight (601 compared with 328, non-LNS compared with LNS) because some participants did not take part in the body composition procedure, there was insufficient sample for analysis, or there were data collection or lab issues.